Vivani Medical Inc. Stock
Vivani Medical Inc. Stock
The Vivani Medical Inc. price is unchanged compared to yesterday.
Currently there is a rather positive sentiment for Vivani Medical Inc. with 4 Buy predictions and 1 Sell predictions.
With a target price of 3 € there is potential for a 246.82% increase which would mean more than doubling the current price of 0.87 € for Vivani Medical Inc..
Our community identified positive and negative aspects for Vivani Medical Inc. stock for the coming years. 1 users see the criterium "Revenue growth" as a plus for the Vivani Medical Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Vivani Medical Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vivani Medical Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vivani Medical Inc. | 0.000% | -5.464% | -12.626% | -1.705% | -15.196% | 11.613% | -95.995% |
| SI-BONE Inc | -0.860% | 1.770% | -4.167% | -1.709% | -31.953% | - | - |
| Lantheus Holdings Inc | -2.150% | 4.059% | -3.782% | -23.633% | 20.105% | -13.192% | - |
| Orasure Tech | 0.000% | -6.015% | -8.088% | -4.580% | 21.359% | -60.630% | -71.258% |
Comments
Vivani Medical (VANI) had its price target lowered by HC Wainwright from $4.00 to $3.50. They now have a "buy" rating on the stock.
Show more
Ratings data for VANI provided by MarketBeat
Vivani Medical (NASDAQ:VANI) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Show more
Ratings data for VANI provided by MarketBeat
Vivani Medical, Inc. (NASDAQ: VANI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Show more
Ratings data for VANI provided by MarketBeat